FreeTrials & Tribulations Why I choose to play a dual role in TMIST May 24, 2019Vol.45 No.21By Worta McCaskill-Stevens
Film & TVFree Chernobyl, the HBO miniseries: Fact and fiction May 17, 2019Vol.45 No.20By Robert Peter Gale
Texas Senate approves $3 billion measure to renew CPRIT funding May 17, 2019Vol.45 No.20By Claire Dietz
ODAC votes down AML drug as FDA raises concerns over equipoise, uncertain efficacy May 17, 2019Vol.45 No.20By Paul Goldberg
Conversation with The Cancer LetterFree Libutti: How Rutgers Cancer Institute became a New Jersey-sized colossus May 17, 2019Vol.45 No.20By Paul Goldberg
FreeTrials & Tribulations Estimating overdiagnosis is hard—we need all the help we can get May 10, 2019Vol.45 No.19By Ruth Etzioni and Roman Gulati
House committee advances FY2020 funding bill giving NIH a $2 billion raise May 10, 2019Vol.45 No.19By Claire Dietz
FDA issues draft guidance on using real world data in drugs, biologics May 10, 2019Vol.45 No.19By Matthew Bin Han Ong
Conversation with The Cancer Letter Georgetown’s Weiner and Hackensack’s Pecora tell us how they created a consortium spanning 233 miles May 10, 2019Vol.45 No.19By Paul Goldberg
NCI approves Georgetown-Hackensack consortiumAre More Long-Distance Relationship In The Works? May 10, 2019Vol.45 No.19By Paul Goldberg
